Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years

Gemma Rossi

Matched on ORCID iD 0000-0003-4071-8247; OpenAlex author ID A5051945781. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 9

  1. Paired Duodenal and Salivary Microbiome Analysis in Pancreatic Cancer Without Duct Obstruction. Co-author DOI 10.1002/ueg2.70179↗
  2. Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. Co-author DOI 10.1016/j.dld.2025.03.009↗
  3. Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy. Co-author DOI 10.1002/deo2.152↗
  4. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples. Co-author DOI 10.1016/j.cgh.2022.10.014↗
  5. EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control stud… Co-author DOI 10.4103/eus-d-21-00200↗
  6. Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients. Co-author DOI 10.1007/s00280-020-04190-1↗
  7. Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomi… Co-author DOI 10.3390/cancers13184512↗
  8. Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer. Co-author DOI 10.1055/a-1221-9879↗
  9. RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features. Co-author DOI 10.3390/cells9122561↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michele Reni · 9 shared papers, 2020–2026 · strength 1.27
  2. Maria Chiara Petrone · 8 shared papers, 2020–2026 · strength 1.15
  3. Massimo Falconi · 8 shared papers, 2020–2026 · strength 1.15
  4. Paolo Giorgio Arcidiacono · 8 shared papers, 2020–2026 · strength 1.15
  5. Gabriele Capurso · 7 shared papers, 2020–2026 · strength 1.01
  6. Lívia Archibugi · 5 shared papers, 2020–2026 · strength 0.77
  7. Sabrina Gloria Giulia Testoni · 6 shared papers, 2020–2023 · strength 0.69
  8. Claudio Doglioni · 5 shared papers, 2020–2023 · strength 0.60
  9. Francesco DE COBELLI · 4 shared papers, 2020–2023 · strength 0.47
  10. Ruggero Ponz de Leon Pisani · 2 shared papers, 2025–2026 · strength 0.44
  11. Marina Macchini · 3 shared papers, 2021–2025 · strength 0.44
  12. Giulia Orsi · 3 shared papers, 2021–2025 · strength 0.44
  13. Gianpaolo Balzano · 3 shared papers, 2021–2023 · strength 0.38
  14. Emanuel Della‐Torre · 3 shared papers, 2020–2022 · strength 0.33
  15. Matteo Tacelli · 2 shared papers, 2023–2025 · strength 0.32
  16. Giuseppe Vanella · 2 shared papers, 2023–2025 · strength 0.32
  17. Domenico Tamburrino · 2 shared papers, 2021–2025 · strength 0.29
  18. Marco Schiavo Lena · 2 shared papers, 2023 · strength 0.28
  19. Giulio Belfiori · 2 shared papers, 2021–2023 · strength 0.25
  20. Miriam Redegalli · 2 shared papers, 2020–2023 · strength 0.24
  21. Giovanni Guarneri · 1 shared paper, 2025 · strength 0.18
  22. Gaetano Lauri · 1 shared paper, 2025 · strength 0.18
  23. Maria Giulia Cangi · 1 shared paper, 2023 · strength 0.14
  24. Diego Palumbo · 1 shared paper, 2023 · strength 0.14
  25. Stefano Crippa · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.